文献速递糖尿病肥胖与代谢综合征

天冬酰胺与谷氨酸稳态改变先于冠心病和2型糖尿病发生

Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2018-01-01

在Malmö预防项目5386人队列中选取1049名无冠心病和糖尿病者,靶向质谱定量35种血浆代谢物,平均随访6.1年。谷氨酸升高与2型糖尿病(OR 1.96)及冠心病(OR 1.28)风险相关,天冬酰胺降低与冠心病(OR 0.80)及复合终点(OR 0.75)相关。

要点

  • 谷氨酸升高与2型糖尿病风险最强相关(OR 1.96)。
  • 谷氨酸升高与冠心病风险相关(OR 1.28),天冬酰胺降低与冠心病风险相关(OR 0.80)。
  • 谷氨酸和天冬酰胺同时与2型糖尿病或冠心病复合终点相关。

核心结论

  • 多种血浆代谢物与2型糖尿病和冠心病发病相关,谷氨酸升高与天冬酰胺降低与两种疾病均相关。
  • 这些关联可能有助于进一步解释2型糖尿病与冠心病为何常共同发生。

研究设计与样本

  • 研究从Malmö预防项目5386人的 population 样本中选取1049名无冠心病和糖尿病个体,平均年龄69.5岁,女性占31%。
  • 采用靶向液相色谱-质谱法定量35种血浆代谢物(氨基酸代谢物和酰基肉碱)。
  • 样本包括204例发生2型糖尿病者、384例发生冠心病者和496例随访期间未发生2型糖尿病和冠心病者,平均随访6.1年。

主要发现

  • 根据logistic回归模型,共16种代谢物与2型糖尿病发病风险显著相关。
  • 谷氨酸与2型糖尿病风险关联最强(OR 1.96;P=5.4e-12),其次为支链氨基酸水平升高。
  • 冠心病发病由三种代谢物预测:谷氨酸(OR 1.28;P=6.6e-4)、组氨酸(OR 0.76;P=5.1e-4)和天冬酰胺(OR 0.80;P=2.2e-3)。
  • 谷氨酸(OR 1.48;P=1.6e-8)和天冬酰胺(OR 0.75;P=1.8e-5)均与发生2型糖尿病或冠心病的复合终点相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Type 2 diabetes mellitus (T2DM) is accompanied by an increased risk for coronary artery disease (CAD), but the overlapping metabolic disturbances preceding both diseases are insufficiently described. OBJECTIVE: We hypothesized that alterations in metabolism occur years before clinical manifestation of T2DM and CAD and that these alterations are reflected in the plasma metabolome. We thus aimed to identify plasma metabolites that predict future T2DM and CAD. DESIGN: Through use of targeted liquid chromatography-mass spectrometry, 35 plasma metabolites (amino acid metabolites and acylcarnitines) were quantified in 1049 individuals without CAD and diabetes, drawn from a population sample of 5386 in the Malmö Preventive Project (mean age, 69.5 years; 31% women). The sample included 204 individuals who developed T2DM, 384 who developed CAD, and 496 who remained T2DM and CAD free during a mean follow-up of 6.1 years. RESULTS: In total, 16 metabolites were significantly associated with risk for developing T2DM according to logistic regression models. Glutamate (OR, 1.96; P = 5.4e-12) was the most strongly associated metabolite, followed by increased levels of branched-chain amino acids. Incident CAD was predicted by three metabolites: glutamate (OR, 1.28; P = 6.6e-4), histidine (OR, 0.76; P = 5.1e-4), and asparagine (OR, 0.80; P = 2.2e-3). Glutamate (OR, 1.48; P = 1.6e-8) and asparagine (OR, 0.75; P = 1.8e-5) were both associated with a composite endpoint of developing T2DM or CAD. CONCLUSION: Several plasma metabolites were associated with incidence of T2DM and CAD; elevated glutamate and reduced asparagine levels were associated with both diseases. We thus discovered associations that might help shed additional light on why T2DM and CAD commonly co-occur.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ottosson F, Smith E, Melander O, et al. Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes. J Clin Endocrinol Metab. 2018. PMID: 29788285. doi:10.1210/jc.2018-00546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。